Articles by G. Steven Burrill - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by G. Steven Burrill

Biotech Remains Upbeat During the Summer

Biotech impressed investors with positive drug data, strong drug sales and earnings, and partnering deals.
Oct 1, 2009

Biotech impressed investors with positive drug data, strong drug sales and earnings, and partnering deals.

Biotech Shows Glimmer of an Upward Trend

Although the markets closed on a positive note in May, it will still take many more months before biotech starts on the road to full recovery.
Jul 1, 2009

Although the markets closed on a positive note in May, it will still take many more months before biotech starts on the road to full recovery.

Biotech Industry Reports a Profit but Many Companies Still Struggle for Survival

Big biotechs will do just fine in the ongoing financial crisis, but the smaller companies will have more difficulty weathering the storm.
Apr 1, 2009

Big biotechs will do just fine in the ongoing financial crisis, but the smaller companies will have more difficulty weathering the storm.

Small-Cap Biotech Companies Conserve Cash to Ride Out The Prevailing Economic Conditions

Small biotechs were forced to restructure and downsize.
Jan 1, 2009

Small biotechs were forced to restructure and downsize.

Will The Biotech Industry Survive The Financial Crisis?

The meltdown in the financial markets will continue to affect the flow of much needed capital into the sector.
Dec 1, 2008

The meltdown in the financial markets represents a sea change in the world of financing that will continue to affect the flow of much needed capital into the sector for the foreseeable future.

Biotech Cruises On Despite a Turbulent Economic Climate

As the financial markets settle down, we will continue to see the biotech industry benefit from increase M&A activity.
Oct 1, 2008

The biotech industry's year-to-date report card contains good grades despite the turbulent economic climate.

Biotech Survives Difficult Opening to 2008

In the current market crisis, biotech IPOs and financing are down, but partnering continues, and M&As are as hot as ever.
Jun 1, 2008

Following the market crisis of the first quarter of 2008, biotech IPOs and financing are down, but partnering continues, and mergers and acquisitions (M&As) remain hot.

What Lies Ahead for Biotech in 2008

Mar 1, 2008

Despite the rising fears about a slowing economy, the biotech industry will continue to maintain its momentum this year.

Biotechnology: Past, Present, and Future

Thirty years after the first biotechnology company opened its doors, the sector is reaching a new level of maturity and globalization.
Oct 1, 2007

Thirty years after the first biotechnology company opened, the sector is reaching a new level of maturity and globalization.

ADVERTISEMENT

ADVERTISEMENT

Click here